Humana (HUM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
16 Apr, 2026Opening remarks and agenda
Meeting opened by the Chairman, with thanks to stockholders and an overview of electronic access to materials.
Rules of conduct outlined, with a Q&A session scheduled after formal business.
Voting window opened for stockholders to cast or change votes.
Board and executive committee updates
Introduction of board members present, with special recognition for a departing director after six years of service.
Shareholder proposals
Stockholder proposal to require shareholder approval for excessive golden parachutes presented and discussed.
Proposal partially adopted in January 2026, but not fully implemented.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Humana
- 2025 adjusted EPS reached $17.14; 2026 targets at least $9.00 EPS and 25% MA growth.HUM
Q4 202514 Apr 2026 - Margin targets, quality membership growth, and strategic acquisitions drive long-term outlook.HUM
Leerink Global Healthcare Conference 202610 Mar 2026 - Proxy covers director elections, executive pay, new stock plan, and ESG priorities.HUM
Proxy Filing6 Mar 2026 - Board recommends approval of all proposals except the golden parachute shareholder proposal.HUM
Proxy Filing6 Mar 2026 - Annual meeting covers director elections, compensation, new equity plan, and ESG progress.HUM
Proxy Filing6 Mar 2026 - Net income declined 29% as higher Medicare Advantage costs offset strong revenue growth.HUM
Q2 20242 Feb 2026 - Stabilized utilization, strategic plan exits, and conservative risk management support 2025 outlook.HUM
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Revenue and MA membership rose, but EPS fell as higher medical costs pressured margins.HUM
Q3 202417 Jan 2026 - 2024 adjusted EPS $16.21; 2025 guidance flat; Medicare Advantage to decline 10%.HUM
Q4 20248 Jan 2026